Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 16 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Large-scale testing (Phase 3)Study completedNCT04635423
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)

Who this might be right for
Warts, GenitalNeoplasms, Anal
Merck Sharp & Dohme LLC 1,059
Large-scale testing (Phase 3)Active Not RecruitingNCT04708041
What this trial is testing

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 700
Post-approval studies (Phase 4)Study completedNCT01101750
What this trial is testing

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Who this might be right for
Cervical CancerHpvWarts
Medstar Health Research Institute 25
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Early research (Phase 1)Enrolling By InvitationNCT06508138
What this trial is testing

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

Who this might be right for
HPV 16 InfectionHPV-Related CarcinomaRecurrence+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Very early researchStudy completedNCT02546752
What this trial is testing

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+2 more
Regenstrief Institute, Inc. 1,306
Not applicableUnknownNCT05587725
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 3

Who this might be right for
Human Papillomavirus InfectionHPVHPV Infection+4 more
Monash University 200
Large-scale testing (Phase 3)Study completedNCT00250276
What this trial is testing

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 798
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Post-approval studies (Phase 4)Active Not RecruitingNCT07314307
What this trial is testing

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Who this might be right for
Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Karolinska Institutet 150,000
Not applicableStudy completedNCT02551887
What this trial is testing

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 647
Testing effectiveness (Phase 2)UnknownNCT06015854
What this trial is testing

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II

Who this might be right for
CIN3Cervical Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 3+1 more
University Medical Center Groningen 18
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Large-scale testing (Phase 3)Study completedNCT00157950
What this trial is testing

Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 176
Testing effectiveness (Phase 2)Study completedNCT00365716
What this trial is testing

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Who this might be right for
Papillomavirus InfectionsGenital Diseases, Female
Merck Sharp & Dohme LLC 1,158
Large-scale testing (Phase 3)Study completedNCT03158220
What this trial is testing

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 1,212
Next Page